The meglumine salt of 1 (5 6 dichloro 1H benzo[d]imidazol 2 yl) 1H pyrazole 4 carboxylic acid (compound (1)) and pharmaceutically acceptable formulations thereof are described. Such compounds may be used in pharmaceutical compositions and methods for the treatment of disease states disorders and conditions mediated by prolyl hydroxylase activity.